Adding new drugs to insulin for type 1 diabetes
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This study tests whether adding certain diabetes pills (GLP-1 receptor agonists or SGLT inhibitors) to insulin is safe and helpful for adults with type 1 diabetes. Doctors will check your glucose monitor data to see how well this works.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have been diagnosed with type 1 diabetes
- Your doctor has prescribed a GLP-1 RA or SGLT inhibitor (like Ozempic, Jardiance, or similar) for any reason, and you have taken it for no more than one week at the time you join
- You use a continuous glucose monitor (CGM) and have CGM data from the past month that can be shared for the study
- You are willing and able to give your informed consent to participate
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether adding the diabetes pill empagliflozin (Jardiance) to your current automated insulin pump can help improve blood sugar control for adults with type 1 diabetes who are not reaching their glucose goals.
This trial tests if adding pioglitazone to an SGLT2 inhibitor can lower blood sugar more and prevent high ketone levels in people with type 1 diabetes. It may help those who have poor blood sugar control despite insulin therapy.
This study tests a system that measures blood sugar and automatically adjusts insulin delivery. It is for adults with type 1 diabetes who use insulin injections or a pump.
This study tests if a special monitoring system can help people with type 1 diabetes use SGLT2i medications safely, alongside insulin and a continuous glucose monitor.
This trial looks at whether adding oral glucose-lowering drugs to your insulin can improve blood sugar control for adults with type 1 diabetes. It compares those who added these drugs to those who stayed on insulin alone.
This trial tests an oral medication that may help your body respond better to insulin. It's for people with type 1 diabetes who use an automated insulin pump and are willing to take a daily pill for 12 weeks.
Hear when a new Type 1 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.